Neogen Corp 8-K, filed Apr 14, 2020
Neogen Corp (NEOG)
About this 8-K
Neogen Corp filed this 8-K on April 14, 2020, reporting on events of April 10, 2020.
Items reported
- Item 5.02: Director or officer change, or executive pay
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
|
|
|
| ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| |
| |
| (Address of principal executive offices) |
(Zip Code) |
Registrant’s telephone number, including area code
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
| N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On April 10, 2020, James L. Herbert informed the Board of Directors of the Company that he was resigning as Chairman of the Board, effective immediately. He will continue to serve on Neogen’s Board of Directors until his term expires in October 2020.
Herbert, 79, is a founder of Neogen, and served as the company’s CEO from its founding in 1982 until July 2017, when John Adent was named to the role. Herbert has served on Neogen’s Board since its inception, and had served as its chairman since 2006.
Jim Borel, 64, who has served on Neogen’s Board since 2016, was named Chairman of the Board, effective this date. He retired in 2016 from DuPont, where he was executive vice president and a member of DuPont’s Office of the Chief Executive, with responsibility for the agriculture and food ingredients businesses of DuPont, as well as several corporate functions. Borel has over 42 years of experience in the global agriculture and food industry.
| Item 9.01 | Financial Statements and Exhibits. |
| (d) | Exhibits |
| 99.1 |
||||
| 104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| NEOGEN CORPORATION | ||||||
| (Registrant) | ||||||
| Date: April 14, 2020 |
||||||
| /s/ Steven J. Quinlan | ||||||
| Steven J. Quinlan | ||||||
| Vice President & CFO |
Exhibit 99.1
FOR IMMEDIATE RELEASE
| CONTACT: | Steve Quinlan, Vice President & CFO |
Neogen Corporation, 517/372-9200
Herbert resigns as Neogen’s Chairman; Borel named as successor
LANSING, Mich., April 10, 2020 — Neogen Corporation (NASDAQ: NEOG) announced today that James Herbert has resigned as its chairman, and he has been succeeded by Jim Borel. Herbert will continue to serve on Neogen’s Board of Directors until his term expires in October 2020.
Herbert, 79, is a founder of Neogen, and served as the company’s CEO from its founding in 1982 until July 2017, when John Adent was named to the role. Herbert has served on Neogen’s Board since its inception, and had served as its chairman since 2006. “I am proud of all that Neogen has become during my 37 years,” said Herbert.
“Clearly, Neogen would not exist without Jim Herbert’s tremendous talent, vision and drive,” said Adent, Neogen’s president and CEO. “He saw a need for what Neogen could become, and has worked tirelessly to achieve his dream. This is not a good-bye, but on behalf of all of Neogen’s employees and other stakeholders past and present, I’d like to thank Jim for everything he has done to make Neogen the great company it is today.”
Borel, 64, has served on Neogen’s Board since 2016. He retired in 2016 from DuPont, where he was executive vice president and a member of DuPont’s Office of the Chief Executive, with responsibility for the agriculture and food ingredients businesses of DuPont, as well as several corporate functions. Borel has over 42 years of experience in the global agriculture and food industry.
“Neogen’s track record of success and leadership over the years is impressive,” said Borel. “I look forward to working with John and the Board to help Neogen continue to grow its results and impact.”
Neogen Corporation develops and markets products dedicated to food and animal safety. The company’s Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen’s Animal Safety Division is a leader in worldwide biosecurity products, animal genomics testing, and the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals and veterinary instruments.
###